Bharat Biotech Says Its Trial of Covaxin Booster Jabs Has Demonstrated "long-term Safety ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'Bharat Biotech says its trial of Covaxin booster jabs has demonstrated "long-term safety with no serious adverse events" "90% of recipients had a detectable neutralizing antibody response against the wild-type strain ," the Covaxin maker says'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)